Evidence map›Paper›PMID 26267255›Full record

ArticlemAbs2015

Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.

Haixia Wu, Kristopher Truncali, Julie Ritchie, Rachel Kroe-Barrett, Sanjaya Singh, Anne S Robinson, Christopher J Roberts

Open access · goldAbstract read
In one paragraph

Article in mAbs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Haixia Wua Department of Chemistry and Biochemistry ; University of Delaware ; Newark , DE USA.
Kristopher Truncalib Department of Biotherapeutics ; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT USA.
Julie Ritchieb Department of Biotherapeutics ; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT USA.
Rachel Kroe-Barrettb Department of Biotherapeutics ; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT USA.
Sanjaya Singhb Department of Biotherapeutics ; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT USA.
Anne S Robinsonc Department of Chemical and Biomolecular Engineering ; Tulane University ; New Orleans , LA USA.
Christopher J Robertsd Department of Chemical and Biomolecular Engineering ; University of Delaware ; Newark , DE USA.
Boehringer Ingelheim (Taiwan) · TWUniversity of Delaware · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Fc (fragment crystallizable) is a common structural region in immunoglobulin gamma (IgG) proteins, IgG-based multi-specific platforms, and Fc-fusion platform technologies. Changes in conformational stability, protein-protein interactions, and aggregation of NS0-produced human Fc1 were quantified experimentally as a function of pH (4 to 6) and temperature (30 to 77 °C), using a combination of differential scanning calorimetry, laser light scattering, size-exclusion chromatography, and capillary electrophoresis. The Fc1 was O-glycosylated at position 3 (threonine), and confirmed to correspond to the intact IgG1 by comparison with Fc1 produced by cleavage of the parent IgG1. Changing the pH caused large effects for thermal unfolding transitions, but it caused surprisingly smaller effects for electrostatic protein-protein interactions. The aggregation behavior was qualitatively similar across different solution conditions, with soluble dimers and larger oligomers formed in most cases. Aggregation rates spanned approximately 5 orders of magnitude and could be divided into 2 regimes: (i) Arrhenius, unfolding-limited aggregation at temperatures near or above the midpoint-unfolding temperature of the CH2 domain; (ii) a non-Arrhenius regime at lower temperatures, presumably as a result of the temperature dependence of the unfolding enthalpy for the CH2 domain. The non-Arrhenius regime was most pronounced for lower temperatures. Together with the weak protein-protein repulsions, these highlight challenges that are expected for maintaining long-term stability of biotechnology products that are based on human Fc constructs.

Indexed as

Protein ConformationTemperatureCalorimetry, Differential ScanningChromatography, GelElectrophoresis, CapillaryGlycosylationHumansHydrogen-Ion ConcentrationImmunoglobulin Fc FragmentsImmunoglobulin GModels, MolecularProtein BindingProtein Structure, TertiaryProtein UnfoldingRecombinant Fusion ProteinsSolutionsImmunoglobulin Fc FragmentsImmunoglobulin GRecombinant Fusion ProteinsSolutionsThreonineantibodykineticsprotein aggregationprotein formulationprotein stability

Identifiers

PMID26267255
PMCPMC4966490
OpenAlexW1959907900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.